DISEASE X is the codename given by the World Health Organisation to a pathogen currently unknown to science that could cause havoc to humankind. Emerging infections are sending us multiple warnings that another Disease X is looming. We've had SARS in 2002, H5N1 bird flu in 2004, H1N1 'swine flu' in 2009, MERS in 2012, Ebola in 2014, Zika in 2015 and now COVID-19. These events are not freak events, but are happening continually, and at an increasing cadence.
Written by a long-standing ex-Reuters global health and science correspondent,Kate Kelland, DISEASE Xuses privileged access to the body leading international efforts to control viral outbreaks, the Coalition for Epidemic Preparedness Innovations (CEPI), and its CEO, Dr Richard Hatchett. CEPI seed-funded three successful COVID vaccines, including the AstraZeneca and Moderna shots. Weaving in insights from the likes of Bill Gates, Erna Solberg, Jeremy Farrar and Seth Berkley, DISEASE X explores the the emergence of the novel coronavirus and the deadly crisis it caused. It analyses the responses of globalhealth organisations and experts, including the WHO; nationalgovernments in Britain, China and the USA; COVAX, theglobal vaccine allocation facility; pharmaceutical companies;and leading research scientists.
Ultimately, DISEASE X is a story of hope. It tells of how, throughout the devastation of Covid, science and human ingenuity have shown that the world can devise intricate new weapons at breath-taking pace against deadly diseases it has never encountered before. It also tells how the world's public health scientists are embarking on a 100 Days Mission to embed that scientific progress into a pandemic-busting plan to defuse future threats from as-yet-unknown pathogens in a little over three months. This is the 100 Days Mission - backed by the G7 and G20 - that will see a newly prepared world, one that can move at speed to snuff out future threats before they become deadly pandemics.